Kura Oncology Inc (KURA) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.55x

Kura Oncology Inc (KURA) has a Cash Flow Reinvestment Rate of 0.55x as of December 2025, reinvesting $64.60 Million (capex $2.32 Million plus investments $-62.27 Million) from operating cash flow of $117.27 Million. Explore Kura Oncology Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.55x
(Capex + Investments) / Operating CF

Total Reinvested

$64.60 Million
Capex + Investments

Operating Cash Flow

$117.27 Million
USD

Capital Expenditures

$2.32 Million
USD

Kura Oncology Inc Cash Flow Reinvestment Rate (2024–2024)

Historical reinvestment intensity for Kura Oncology Inc across 1 annual periods. Also explore Kura Oncology Inc assets under control for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Kura Oncology Inc (2024–2024)

Year-by-year capital reinvestment analysis for Kura Oncology Inc. For live market cap and broader valuation context, see Kura Oncology Inc (KURA) total market value.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2024 0.76x $102.06 Million $134.32 Million $472.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow